February 2020 | Volume 2
Re-reading the articles in this edition gives me hope that our healthcare ecosystem is beginning to reflect a patient-centered culture and that the results are as powerful as patient advocates consistently forecast. Industry leaders from pharmaceuticals and health systems to data technology giants are setting a high bar for social consciousness and doing the right thing for the patient FIRST. Short-term investments may be higher, but the gain in health, patient agency and transparency is a universal gain. The conversation about value is evolving to focus on patient-defined factors that affect their decision-making and their outcomes. To paraphrase Intermountain’s CEO, value is being "redefined in terms of healthiness over affordability over time." Growing evidence demonstrates that patient-partnered research can accelerate finding clues that are leading to potential cures. And, clinicians are pushing back on systems like prior authorization and the primacy of clinical guidelines, not to imply that they have no importance, but to highlight their inefficiency and lack of relevance to real-world, everyday decision making that must occur with patients that don’t look "average”. Change is good. And patients are the compass that guides the way.
How to Make Value Assessment More Relevant to Healthcare Decisions
In American healthcare today there are certain hard truths, starting with this one: far too many prescription drugs are shockingly (and often unjustifiably) expensive. There is a second truth as well—the cost of healthcare, drugs or otherwise, is seldom based on its actual value.
Merck Has A Great Future, Because It Has A Soul: Ken Frazier
Listen to this conversation I had with with Ken Frazier when we honored him with the first Forbes Healthcare Lifetime Achievement Award last December, and you’ll quickly realize why he is one of the most effective and inspiring big company leaders today and why Merck’s prospects in the pharmaceutical field have never been brighter.
Apple, Cerner call for interoperability rule release 'without further delay,' highlighting industry rift
Big tech giants Apple and Microsoft are joining health IT vendors and health plans to meet with federal officials today to voice strong support for efforts to give patients access to their health data.
Open science, publishing, and public research support: Could Trump have it right?
In the three years since Donald Trump was inaugurated as president, I have rarely supported anything he proposed. And for nearly 50 years as an academic researcher, I have almost always sided with the professional research establishment. Yet on one issue I now find myself siding with the president and opposing the scientific establishment.
Changing the Game of Prior Authorization - The Patient Perspective
Securing approval for reimbursement of care in a medical care system affected by overuse and ineffective care seems logical and arguably protective of patients’ interests. However, the prior authorization process has now become a significant burden on clinicians, patients, and health care organizations.
Bridging the Gap Between Where the Quality Metric Ends and Real Life Begins—A Trusting Relationship
A few weeks ago, I was poring over the latest evidence-based guidelines for treating hypertension with one of our medical students, hoping it would enlighten us regarding how to craft our recommendations for a patient with persistent hypertension whom I had known for 15 years.
Patient-partnered research finds clues about a rare cancer’s genetic roots
For over three decades, Jim Chapdelaine thought he’d never meet another person who had the rare, aggressive cancer he’d battled since 1976, known as angiosarcoma. Even his doctors thought his diagnosis must be a mistake because so few patients get the disease.
Short-Term Loss, Long-Term Gain: Encouraging Bottom-Up Ideas That Revise the Value Equation
In a discussion with NEJM Catalyst, Marc Harrison, MD, CEO of Intermountain Healthcare, describes the progress of Intermountain One, an initiative that encourages — and benefits from — staff ideas to improve care and enhance value.

Passion + Quality = Change That Matters
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534